| Literature DB >> 16151390 |
Abstract
Ensuring adequate manufacturing capacity for recombinant and monoclonal antibodies is one of the greatest challenges facing the biotech industry. The following factors should be taken into account when designing product development and production strategies.Mesh:
Substances:
Year: 2005 PMID: 16151390 DOI: 10.1038/nbt0905-1054
Source DB: PubMed Journal: Nat Biotechnol ISSN: 1087-0156 Impact factor: 54.908